Tidal Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
31,325
+10,083
| +47% | +$554K | 0.01% | 762 |
|
|
2025
Q1 | $1.5M | Buy |
21,242
+8,203
| +63% | +$580K | 0.01% | 794 |
|
|
2024
Q4 | $857K | Sell |
13,039
-17,428
| -57% | -$1.15M | 0.01% | 1061 |
|
|
2024
Q3 | $2.14M | Buy |
30,467
+18,300
| +150% | +$1.29M | 0.02% | 597 |
|
|
2024
Q2 | $1M | Sell |
12,167
-5,280
| -30% | -$435K | 0.01% | 882 |
|
|
2024
Q1 | $1.52M | Buy |
17,447
+6,906
| +66% | +$603K | 0.03% | 654 |
|
|
2023
Q4 | $1.02M | Buy |
10,541
+55
| +0.5% | +$5.3K | 0.02% | 615 |
|
|
2023
Q3 | $928K | Buy |
10,486
+568
| +6% | +$50.3K | 0.03% | 572 |
|
|
2023
Q2 | $860K | Buy |
9,918
+3,760
| +61% | +$326K | 0.03% | 589 |
|
|
2023
Q1 | $599K | Buy |
6,158
+388
| +7% | +$37.7K | 0.02% | 685 |
|
|
2022
Q4 | $597K | Buy |
5,770
+719
| +14% | +$74.4K | 0.02% | 606 |
|
|
2022
Q3 | $428K | Buy |
5,051
+284
| +6% | +$24.1K | 0.02% | 621 |
|
|
2022
Q2 | $395K | Sell |
4,767
-25
| -0.5% | -$2.07K | 0.01% | 678 |
|
|
2022
Q1 | $369K | Buy |
4,792
+474
| +11% | +$36.5K | 0.01% | 766 |
|
|
2021
Q4 | $381K | Buy |
4,318
+204
| +5% | +$18K | 0.01% | 694 |
|
|
2021
Q3 | $318K | Buy |
4,114
+655
| +19% | +$50.6K | 0.01% | 666 |
|
|
2021
Q2 | $289K | Sell |
3,459
-25
| -0.7% | -$2.09K | 0.01% | 585 |
|
|
2021
Q1 | $263K | Buy |
3,484
+1,023
| +42% | +$77.2K | 0.01% | 465 |
|
|
2020
Q4 | $216K | Buy |
+2,461
| New | +$216K | 0.01% | 378 |
|
|
2020
Q3 | – | Sell |
-1,653
| Closed | -$204K | – | 246 |
|
|
2020
Q2 | $204K | Buy |
+1,653
| New | +$204K | 0.03% | 286 |
|